Description
Part 1: Overview of Organ Allocation Strategies in Different Countries. 1. Principles for Allocation of Cadaver Organs to Transplant Recipients and Coordinating Procedures in Spain; B. Miranda, J.M. Gonzlez-Posada. 2. Principles and Practice of Cadaver Organ Allocation in France; C. Jacquelinet, D. Houssin. 3. Principles for Allocation of Cadaver Organs to Transplant Recipients in Italy; M. Cardillo, et al. 4. Allocation of Cadaver Organs to Transplant Recipients in Scandiatransplant; M. Madsen, et al. 5. Principles for Allocation of Cadaver Organs to Transplant Recipients in the USA (UNOS); W.W. Pfaff. 6. Allocation of Kidneys in the UK; P.M. Moriss, S. Fuggle. Part 2: Principles Underlying Current Policies in Organ Allocation. 7. What to Expect from a Good Kidney Allocation System; G. Opelz, T. Wujciak. 8. Allocation of Cadaver Organs to Transplant Recipients in Eurotransplant: Principles and Policies, Anno 1998; J. De Meester, G.G. Persijn. 9. Increasing Kidney Supply as the Best Solution to the Allocation Problem; P.I. Terasaki, et al. 10. Strategies in Organ Donation; R.A. Sells. 11. World Health Organization Guidelines on Transplantation and the WHO Task Force; B.M. Dickens. Part 3: Waiting List. 12. The French Liver Transplant Waiting List: 5-year Analysis (1992-1996); B. Suc. 13. Predictors of Multiple Listing for Cadaver Kidney Transplantation and the Effects of a Ban on Multiple Listing in the United States – A Summary; R. J. Ozminkowski, et al. 14. Allocation of Kidneys to Patients on the Transplant Waiting List: A Simulation-Based Policy Model; S.A. Zenios, et al. 15. Factors Influencing Early Placement on the Kidney Transplant Waiting List in the United States; B.L. Kasiske, et al. 16. The Organ Transplant Waiting List in France; P. Romano, et al. Part 4: At-Risk Donors. 17. Expanded Donor Pool; M. Manyalich, et al. 18. Non Heart-Beating Donors; P. Squifflet. 19. How to Reconcile Virological Safety and Efficacy in Organ Procurement; H. Agut. 20. Donors with Bacterial Infection in Organ Transplantation; A. Pahissa. 21. Further Readings on Allocation of Organs from At-Risk Donors; D. Forti. Part 5: Ischemia Reperfusion and Organ Allocation. 22. The Inflammatory Cascade of Liver Ischemia and Reperfusion: From the Donor to the Recipient; O. Le Moine, et al. 23. The Role of T-Cell Costimulatory Pathways in Ischemia-Reperfusion Injury; A. Chandraker, M.H. Sayegh. 24. Interest in an Anti-LFA-1 Monoclonal Antibody in the Prevention of Reperfusion Injury in Kidney Transplantation; M. Hourmant, J.P. Soulillou. 25. Preservation Solution in Heart Transplantation; P. Menasch. 26. The Impact of Ischemia-Reperfusion Injury on Specific and Non- Specific, Early and Late Chronic Events after Organ Transplantation; W. Land, K. Memer. 27. Pharmacological Intervention to Decrease Ischemia-Reperfusion Injury; J.M. Griny. Part 6: Living Donors and Organ Allocation. 28. Organ Transplantation in Islam; M.A. Mahmoud. 29. Liver Donor Transplantation in Sweden and Other Nordic Countries with Emphasis on the Benefits of the Procedure; G. Tufveson, et al. 30. Kidney Paired Exchange Programs: An Expanded View of the Ethical Issues; L. Friedman Ross, E.S. Woodle. 31. Unconventional Living Kidney Donors; A. Spital. Index of Names.
